Brought to you by 
AbbVie, Pure MHC sign cancer alliance
12 Jan 2017
Executive Summary
Pure Protein LLC's subsidiary Pure MHC LLC is teaming up with AbbVie Inc. in the discovery and validation of peptide targets for use with T-cell receptor therapies aimed at various cancers.
Deal Industry
- Pharmaceuticals
-
Biotechnology
- Large Molecule
Deal Status
- Final
Deal Type
-
Alliance
- R&D and Marketing (Licensing)
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com